According to our (Global Info Research) latest study, the global AI Cardiovascular Ultrasound Solution market size was valued at US$ 631 million in 2025 and is forecast to a readjusted size of US$ 2515 million by 2032 with a CAGR of 21.7% during review period.
AI Cardiovascular Ultrasound Solutions are artificial intelligence–enabled software and system platforms designed to enhance cardiac and vascular ultrasound imaging by automating image acquisition, interpretation, quantification, and clinical reporting. These solutions typically integrate with echocardiography systems to provide real-time scan guidance, standardized view recognition, automated measurements such as ejection fraction (EF), global longitudinal strain (GLS), and valve parameters, as well as detection of structural and functional abnormalities. By reducing operator dependency and inter-observer variability, AI cardiovascular ultrasound improves diagnostic consistency, workflow efficiency, and throughput in cardiology departments, echocardiography labs, intensive care units, and point-of-care settings. Depending on regulatory status, products may function as clinical decision support tools or as regulated Software as a Medical Device (SaMD) supporting diagnostic use.
From a classification perspective, the market can be parameterized by application scope (echocardiography, stress echo, vascular ultrasound, hemodynamic assessment), AI functional depth (scan guidance, automated quantification, disease classification, decision support), care setting (cardiology labs, ICU, emergency/POCUS, outpatient screening), and deployment model (on-device embedded AI, hybrid edge–cloud platforms, cloud-based analytics, or plug-in software for existing systems). These dimensions align with how hospitals and imaging centers evaluate solutions, balancing clinical scope, integration complexity, regulatory clearance, and total cost of ownership.
The industry value chain begins upstream with ultrasound system manufacturers, transducer suppliers, and semiconductor providers, followed by midstream AI algorithm developers and software platform vendors. Downstream customers include hospitals, cardiac imaging centers, and outpatient clinics, with purchasing decisions often influenced by compatibility with existing ultrasound fleets and PACS/EMR systems. Gross margins are generally attractive for AI cardiovascular ultrasound solutions due to their software-driven nature, though margins may be moderated by clinical validation, regulatory compliance, and integration services. Transactions typically start with pilot deployments, followed by multi-year licenses priced per device, per site, or per exam volume. Market trends include deeper AI automation at the device level, expansion from measurement-focused tools to disease-level intelligence, increasing regulatory approvals, and broader adoption in POCUS and preventive cardiovascular screening.
This report is a detailed and comprehensive analysis for global AI Cardiovascular Ultrasound Solution market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Cardiovascular Ultrasound Solution market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Cardiovascular Ultrasound Solution market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Cardiovascular Ultrasound Solution market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Cardiovascular Ultrasound Solution market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Cardiovascular Ultrasound Solution
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Cardiovascular Ultrasound Solution market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE HealthCare, Philips, Siemens Healthineers, Canon Medical Systems, Samsung Medison, Mindray, Butterfly Network, Exo, Clarius, UltraSight, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Cardiovascular Ultrasound Solution market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Equipment
Software
Market segment by System Architecture & Commercial Model
On-device / Embedded AI Solutions
Hybrid Edge–Cloud AI Platforms
AI Plug-ins for Existing Ultrasound Systems
Others
Market segment by AI Function Depth
Scan Guidance & View Recognition
Automated Measurement & Quantification
Structural & Functional Abnormality Detection
Disease Classification & Risk Stratification
Others
Market segment by Application
Hospital
Clinic
Other
Market segment by players, this report covers
GE HealthCare
Philips
Siemens Healthineers
Canon Medical Systems
Samsung Medison
Mindray
Butterfly Network
Exo
Clarius
UltraSight
Us2.ai
Ultromics
United Imaging
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Cardiovascular Ultrasound Solution product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Cardiovascular Ultrasound Solution, with revenue, gross margin, and global market share of AI Cardiovascular Ultrasound Solution from 2021 to 2026.
Chapter 3, the AI Cardiovascular Ultrasound Solution competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Cardiovascular Ultrasound Solution market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Cardiovascular Ultrasound Solution.
Chapter 13, to describe AI Cardiovascular Ultrasound Solution research findings and conclusion.
Summary:
Get latest Market Research Reports on AI Cardiovascular Ultrasound Solution. Industry analysis & Market Report on AI Cardiovascular Ultrasound Solution is a syndicated market report, published as Global AI Cardiovascular Ultrasound Solution Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AI Cardiovascular Ultrasound Solution market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.